Francine Foss, MD, reviews optimal management of a highly functional patient presenting with de novo tumor-stage mycosis fungoides.
Upon completion of this activity, participants should be able to:
Key Studies in Hematologic Malignancies
B-Cell Malignancies (Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia): ClinicalThought™ 2015
Management of Patients With Localized Follicular Lymphoma
Poorer Outcomes With Rituximab + Chemo in Heavier Patients, Older Men With Follicular Lymphoma
GADOLIN: Obinutuzumab + Bendamustine and Maintenance Obinutuzumab in Rituximab-Refractory Indolent NHL
Conference CoverageEducationClinicalThoughtDecision SupportCCO Live EventsSlidesets & Resources
Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.
Clinical Care Options, LLC. All Rights Reserved.